CN106177775A - A kind of Chinese medicine composition treating hyperosteogeny - Google Patents
A kind of Chinese medicine composition treating hyperosteogeny Download PDFInfo
- Publication number
- CN106177775A CN106177775A CN201610701268.7A CN201610701268A CN106177775A CN 106177775 A CN106177775 A CN 106177775A CN 201610701268 A CN201610701268 A CN 201610701268A CN 106177775 A CN106177775 A CN 106177775A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- chinese medicine
- rhizoma
- herba lysimachiae
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/58—Reptiles
- A61K35/586—Turtles; Tortoises, e.g. terrapins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/24—Apocynaceae (Dogbane family), e.g. plumeria or periwinkle
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/254—Acanthopanax or Eleutherococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/284—Atractylodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/36—Caryophyllaceae (Pink family), e.g. babysbreath or soapwort
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/37—Celastraceae (Staff-tree or Bittersweet family), e.g. tripterygium or spindletree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/72—Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/758—Zanthoxylum, e.g. pricklyash
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
- A61K36/8884—Arisaema, e.g. Jack in the pulpit
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/894—Dioscoreaceae (Yam family)
- A61K36/8945—Dioscorea, e.g. yam, Chinese yam or water yam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
- A61K36/8994—Coix (Job's tears)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to a kind of Chinese medicine composition treating hyperosteogeny, its raw material of Chinese medicine and weight be: Radix Flemingiae Philippinensis 10 30 parts, Bi 5 25 parts, Semen Coicis 5 25 parts, Rhizoma Atractylodis 5 20 parts, Radix Et Caulis Acanthopanacis Senticosi 5 25 parts, deer grass 5 25 parts, Radix Fici tikouae 5 25 parts, 5 20 parts of Rhizoma Curcumae Longae, Radix Stellariae Yunnanensis 5 25 parts, Rhizoma Curculiginis 5 25 parts, Radix Celastri Orbiculati 5 25 parts, Radix Zanthoxyli 5 20 parts, Radix berchemiae lineatae 5 25 parts, Carapax et Plastrum Testudinis 5 25 parts, Flos Woodfordiae Fruticosae 5 25 parts, Cortex Cinnamomi 5 20 parts, Herba Lysimachiae Clethroids (Radix Seu Herba Lysimachiae Clethroidis) 5 25 parts, 5 25 parts of Radix Rubiae, thorn youth fruit 5 25 parts, Radix Oenotherae erythrosepalae 5 25 parts, Rhizoma Arisaematis 5 20 parts, Caulis et Folium (Gouaniae Leptostachyae) 5 25 parts, Radix Cyanotis vagae 5 25 parts, 5 15 parts of Radix Glycyrrhizae.The Chinese medicine composition of the present invention has effect of the liver and the kidney tonifying, drying dampness to eliminate phlegm, expelling wind and cold, blood circulation promoting and blood stasis dispelling, dredge the meridian passage, anti-inflammatory analgetic, and its treatment hyperosteogeny is evident in efficacy, reliable effect.
Description
Technical field
The present invention relates to the pharmaceutical product not determining structure of a kind of traditional herbal medicines, especially one treats hyperosteogeny
Chinese medicine composition.
Background technology
Hyperosteogeny is also called hyperplastic osteoarthritis, osteoarthritis (OA), degenerative joint disease, senile joint
Inflammation, soft tissue degeneration, the degenerations such as hypertrophiarthritis, is owing to constituting the cartilage in joint, intervertebral disc, ligament, joint margins shape
Become bony spur, the changes such as synovial membrane is plump, and osteoclasia occurs, cause insecondary hyperosteogeny, cause joint deformity, when by different
During Chang Zaihe, cause arthralgia, a kind of disease of the symptoms such as limitation of activity.Hyperosteogeny is common clinical, and frequently-occurring disease is again
It it is difficult disease.The method for the treatment of hyperosteogeny has two kinds at present: one, western medicine, the principle of western medicine hyperosteogeny is all
Antiinflammatory, pain relieving, its common medicine is non-steroid anti-inflammation analgesic, such as ibuprofen, ketoprofen, ibuprofen etc., say, that the most temporarily
Time alleviate a little misery, the cause of disease also exists, Relapse rate after drug withdrawal, and Long-term taking medicine toxic and side effects is big, impairing the liver kidney.Two, operation is controlled
Treating, operative treatment is that hypertrophy position is removed, painful big, it is easy to recurrence, patient is not easily accepted by.
The traditional Chinese medical science thinks that hyperosteogeny belongs to " arthromyodynia " category of the traditional Chinese medical science, also known as " rheumatism involving the bone ".Hyperosteogeny and wound, strain, the stasis of blood
Blood resistance network, the damp that is affected by the cold, phlegm resistance, caused by liver and kidney deficiency etc. are relevant.
According to theory of Chinese medical science, for the pathogeny of hyperosteogeny, use the liver and the kidney tonifying, drying dampness to eliminate phlegm, expelling wind and cold, work
Blood blood stasis dispelling, dredge the meridian passage, the method for the treatment of of anti-inflammatory analgetic, carry out dialectical composition of prescription, to reach the purpose for the treatment of both the principal and secondary aspects of a disease.
Summary of the invention
In order to overcome treatment hyperosteogeny in prior art to there is big and easily recurrence the deficiency of toxic and side effects, the present invention provides
A kind of prepare simplicity, low cost, evident in efficacy, the Chinese medicine composition for the treatment of hyperosteogeny that has no side effect.
The technical solution adopted for the present invention to solve the technical problems is: a kind of Chinese medicine composition treating hyperosteogeny,
It is characterized in that: its raw material of Chinese medicine and weight be: Radix Flemingiae Philippinensis 10-30 part, Bi 5-25 part, Semen Coicis 5-25 part, grey
Art 5-20 part, Radix Et Caulis Acanthopanacis Senticosi 5-25 part, deer grass 5-25 part, Radix Fici tikouae 5-25 part, Rhizoma Curcumae Longae 5-20 part, Radix Stellariae Yunnanensis 5-25 part,
Rhizoma Curculiginis 5-25 part, Radix Celastri Orbiculati 5-25 part, Radix Zanthoxyli 5-20 part, Radix berchemiae lineatae 5-25 part, Carapax et Plastrum Testudinis 5-25 part, Flos Woodfordiae Fruticosae 5-25 part,
Cortex Cinnamomi 5-20 part, Herba Lysimachiae Clethroids (Radix Seu Herba Lysimachiae Clethroidis) 5-25 part, Radix Rubiae 5-25 part, thorn youth fruit 5-25 part, Radix Oenotherae erythrosepalae 5-25 part, Rhizoma Arisaematis 5-20 part, under
Really rattan 5-25 part, Radix Cyanotis vagae 5-25 part, Radix Glycyrrhizae 5-15 part.
The preferred technical solution of the present invention is: a kind of Chinese medicine composition treating hyperosteogeny, it is characterised in that: its Chinese medicine
Raw material and weight be: Radix Flemingiae Philippinensis 20 parts, Bi 15 parts, Semen Coicis 15 parts, Rhizoma Atractylodis 10 parts, Radix Et Caulis Acanthopanacis Senticosi 15 parts, deer grass
15 parts, Radix Fici tikouae 15 parts, 10 parts of Rhizoma Curcumae Longae, Radix Stellariae Yunnanensis 15 parts, Rhizoma Curculiginis 15 parts, Radix Celastri Orbiculati 15 parts, Radix Zanthoxyli 10 parts, ferrum bag
Gold 15 parts, Carapax et Plastrum Testudinis 15 parts, Flos Woodfordiae Fruticosae 15 parts, Cortex Cinnamomi 10 parts, Herba Lysimachiae Clethroids (Radix Seu Herba Lysimachiae Clethroidis) 15 parts, 15 parts of Radix Rubiae, thorn youth fruit 15 parts, Radix Oenotherae erythrosepalae 15
Part, Rhizoma Arisaematis 10 parts, Caulis et Folium (Gouaniae Leptostachyae) 15 parts, Radix Cyanotis vagae 15 parts, 10 parts of Radix Glycyrrhizae.
Chinese medicine composition of the present invention is under Traditional Chinese medical theory and clinical experience instruct, selected medicament composing prescription.The present invention
In Chinese medicine composition: Radix Flemingiae Philippinensis has relaxing muscles and tendons and activating QI and blood in the collateral, effect of strong waist knee joint；Bi has dampness removing and goes turbid, to dispel the wind blood stasis dispelling merit
Effect；Semen Coicis has inducing diuresis to remove edema, spleen invigorating is dried, effect of arthralgia relieving by relaxing muscles and tendons, clearing away heat and discharging pus；Rhizoma Atractylodis have drying damp and strengthening spleen, dispel the wind
Effect of cold expelling；Radix Et Caulis Acanthopanacis Senticosi has effect of replenishing QI to invigorate the spleen, tonifying the kidney for tranquilization；Deer grass has the kidney invigorating bone strengthening, expelling wind and removing dampness, stops
The effect cough, stopped blooding；Radix Fici tikouae has effect of clearing away heat-damp and promoting diuresis, reducing swelling and alleviating pain；Rhizoma Curcumae Longae has the merit of removing blood stasis circulation of qi promoting, inducing menstruation to relieve menalgia
Effect；Radix Stellariae Yunnanensis has effect of strengthening spleen and nourishing blood, the liver and the kidney tonifying, detumescence；Rhizoma Curculiginis have reinforcing the kidney and supporting YANG, benefiting essence-blood, bone and muscle strengthening,
Effect of promoting the circulation of blood detumescence；Radix Celastri Orbiculati has effect of expelling wind and removing dampness, promoting blood circulation to restore menstrual flow, subduing swelling and detoxicating；Radix Zanthoxyli only has circulation of qi promoting
Bitterly, effect of blood circulation promoting and blood stasis dispelling, dispelling wind and removing obstruction in the collateral；Radix berchemiae lineatae has effect of subduing swelling and detoxicating, hemostatic analgesia, expelling wind and removing dampness；Carapax et Plastrum Testudinis has
There are nourishing kidney YANG hyperactivity suppressing, replenishing kidney and strengthening bone, the effect of reinforcing the heart of nourishing blood；Flos Woodfordiae Fruticosae has the merit of regulating menstruation and activating blood, cooling blood for hemostasis, dredge the meridian passage
Effect；Cortex Cinnamomi has benefit supporing yang, effect of dispersing cold for relieving pain, promoting blood circulation to restore menstrual flow of fire；Herba Lysimachiae Clethroids (Radix Seu Herba Lysimachiae Clethroidis) has clearing away heat-damp and promoting diuresis, promoting blood circulation to remove blood stasis, removing toxic substances
Effect of eliminating carbuncle；Effect that Radix Rubiae has cooling blood for hemostasis, blood stasis dispelling is stimulated the menstrual flow；Thorn youth fruit has effect of heat-clearing and toxic substances removing, anti-inflammatory analgetic；
Radix Oenotherae erythrosepalae has effect of bone and muscle strengthening, expelling wind and removing dampness；Rhizoma Arisaematis have drying dampness to eliminate phlegm, expelling wind and relieving convulsion, effect of mass dissipating and swelling eliminating；
Caulis et Folium (Gouaniae Leptostachyae) has removing pathogenic heat from blood and toxic substance from the body, effect of relaxing muscles and tendons and activating QI and blood in the collateral；Radix Cyanotis vagae have dispelling, collateral-activating, inducing diuresis and reducing edema, move back weakness effect；Sweet
Grass has effect of invigorating the spleen and replenishing QI, heat-clearing and toxic substances removing, expelling phlegm for arresting cough, coordinating the actions of various ingredients in a prescription.The selected medicament composing prescription of the present invention, its drug component
Through dialectical compatibility, help using mutually assistant, play altogether the liver and the kidney tonifying, drying dampness to eliminate phlegm, expelling wind and cold, blood circulation promoting and blood stasis dispelling, dredge the meridian passage,
Effect of anti-inflammatory analgetic, the treatment to hyperosteogeny reaches treating both the principal and secondary aspects of a disease.
The component of the present composition all uses natural raw material of Chinese medicine, and its preparation is easy, medicine source is wide, low cost.This
The bright prescriptions principle following the traditional Chinese medical science, various component drug use the use that is decocted in water for oral dose.Checking and middle adverse drug by clinic application
Reaction (ADR) safety evaluatio, it is evident in efficacy, safe and reliable, mild in medicine property and, do not occur that toxic and side effects, effective percentage reach
96.5%, cure rate 75%.
Detailed description of the invention
Below in conjunction with embodiment, the invention will be further described.
Embodiment 1
A kind of Chinese medicine composition treating hyperosteogeny, its raw material of Chinese medicine and weight proportion be: Radix Flemingiae Philippinensis 20g, Bi 15g, the heart of a lotus seed
Semen Coicis 15g, Rhizoma Atractylodis 10g, Radix Et Caulis Acanthopanacis Senticosi 15g, deer grass 15g, Radix Fici tikouae 15g, Rhizoma Curcumae Longae 10g, Radix Stellariae Yunnanensis 15g, Rhizoma Curculiginis 15g,
Radix Celastri Orbiculati 15g, Radix Zanthoxyli 10g, Radix berchemiae lineatae 15g, Carapax et Plastrum Testudinis 15g, Flos Woodfordiae Fruticosae 15g, Cortex Cinnamomi 10g, Herba Lysimachiae Clethroids (Radix Seu Herba Lysimachiae Clethroidis) 15g, Radix Rubiae 15g,
Thorn youth fruit 15g, Radix Oenotherae erythrosepalae 15g, Rhizoma Arisaematis 10g, Caulis et Folium (Gouaniae Leptostachyae) 15g, Radix Cyanotis vagae 15g, Radix Glycyrrhizae 10g.
Embodiment 2
A kind of Chinese medicine composition treating hyperosteogeny, its raw material of Chinese medicine and weight proportion be: Radix Flemingiae Philippinensis 15g, Bi 25g, the heart of a lotus seed
Semen Coicis 10g, Rhizoma Atractylodis 20g, Radix Et Caulis Acanthopanacis Senticosi 5g, deer grass 25g, Radix Fici tikouae 10g, Rhizoma Curcumae Longae 20g, Radix Stellariae Yunnanensis 5g, Rhizoma Curculiginis 25g, south
Mabi root 10g, Radix Zanthoxyli 20g, Radix berchemiae lineatae 5g, Carapax et Plastrum Testudinis 25g, Flos Woodfordiae Fruticosae 10g, Cortex Cinnamomi 20g, Herba Lysimachiae Clethroids (Radix Seu Herba Lysimachiae Clethroidis) 5g, Radix Rubiae 25g, thorn youth
Really 10g, Radix Oenotherae erythrosepalae 20g, Rhizoma Arisaematis 5g, Caulis et Folium (Gouaniae Leptostachyae) 25g, Radix Cyanotis vagae 10g, Radix Glycyrrhizae 15g.
Embodiment 3
A kind of Chinese medicine composition treating hyperosteogeny, its raw material of Chinese medicine and weight proportion be: Radix Flemingiae Philippinensis 25g, Bi 10g, the heart of a lotus seed
Semen Coicis 20g, Rhizoma Atractylodis 5g, Radix Et Caulis Acanthopanacis Senticosi 25g, deer grass 10g, Radix Fici tikouae 20g, Rhizoma Curcumae Longae 5g, Radix Stellariae Yunnanensis 25g, Rhizoma Curculiginis 10g, south
Mabi root 20g, Radix Zanthoxyli 5g, Radix berchemiae lineatae 25g, Carapax et Plastrum Testudinis 10g, Flos Woodfordiae Fruticosae 20g, Cortex Cinnamomi 5g, Herba Lysimachiae Clethroids (Radix Seu Herba Lysimachiae Clethroidis) 25g, Radix Rubiae 10g, thorn youth
Really 20g, Radix Oenotherae erythrosepalae 5g, Rhizoma Arisaematis 15g, Caulis et Folium (Gouaniae Leptostachyae) 10g, Radix Cyanotis vagae 20g, Radix Glycyrrhizae 5g.
Embodiment 4
A kind of Chinese medicine composition treating hyperosteogeny, its raw material of Chinese medicine and weight proportion be: Radix Flemingiae Philippinensis 10g, Bi 20g, the heart of a lotus seed
Semen Coicis 5g, Rhizoma Atractylodis 15g, Radix Et Caulis Acanthopanacis Senticosi 10g, deer grass 20g, Radix Fici tikouae 5g, Rhizoma Curcumae Longae 15g, Radix Stellariae Yunnanensis 10g, Rhizoma Curculiginis 20g, south
Mabi root 5g, Radix Zanthoxyli 15g, Radix berchemiae lineatae 10g, Carapax et Plastrum Testudinis 20g, Flos Woodfordiae Fruticosae 5g, Cortex Cinnamomi 15g, Herba Lysimachiae Clethroids (Radix Seu Herba Lysimachiae Clethroidis) 10g, Radix Rubiae 20g, thorn youth
Really 5g, Radix Oenotherae erythrosepalae 25g, Rhizoma Arisaematis 12g, Caulis et Folium (Gouaniae Leptostachyae) 20g, Radix Cyanotis vagae 5g, Radix Glycyrrhizae 8g.
Embodiment 5
A kind of Chinese medicine composition treating hyperosteogeny, its raw material of Chinese medicine and weight proportion be: Radix Flemingiae Philippinensis 30g, Bi 5g, Semen Coicis
Core 25g, Rhizoma Atractylodis 12g, Radix Et Caulis Acanthopanacis Senticosi 20g, deer grass 5g, Radix Fici tikouae 25g, Rhizoma Curcumae Longae 12g, Radix Stellariae Yunnanensis 20g, Rhizoma Curculiginis 5g, south Serpentis
Rattan 25g, Radix Zanthoxyli 12g, Radix berchemiae lineatae 20g, Carapax et Plastrum Testudinis 5g, Flos Woodfordiae Fruticosae 25g, Cortex Cinnamomi 12g, Herba Lysimachiae Clethroids (Radix Seu Herba Lysimachiae Clethroidis) 20g, Radix Rubiae 5g, thorn youth fruit
25g, Radix Oenotherae erythrosepalae 10g, Rhizoma Arisaematis 20g, Caulis et Folium (Gouaniae Leptostachyae) 5g, Radix Cyanotis vagae 25g, Radix Glycyrrhizae 12g.
Chinese medicine composition in embodiment of the present invention decocting method routinely produces medicament.Concrete grammar is as follows: by prescription
Raw material of Chinese medicine put in container, add cold water and cover powder, soak 15～20 minutes, added water no powder about 6 centimetres, and carried out
Decoct for the first time, at a simmer before use intense fire to decoct, with slow fire boiling 20～30 minutes after boiling；Second time decocts, and added water no medicine
About 4 centimetres of face, decocts 15～20 minutes after water boiling.Decoct extracting juice twice, merge.
The present invention, with a kind of Chinese medicine composition treating hyperosteogeny given by embodiment 1, does clinical efficacy and sums up such as
Under:
One, general data: this Chinese medicine composition is applied to clinical observation case 85 example, male 49 examples, female 36 example, age 40～75
Year.
Two, diagnosis basis:
(1) primary multiple life was at about 50 years old, and Secondary cases mostly occurs at about 40 years old；
(2) pain, pain relief or disappearance during inertia during activity；
(3) function of joint is the most limited, has deformity in various degree late period；
(4) X line shows as joint space and narrows, joint margins lip sample hypertrophy, and hyperosteogeny is formed.Advanced joint cartilage substantially destroys,
Joint space substantially narrows, joint deformity and subluxation.
Three, usage and dosage: during clinical practice, potion on the one, decocting twice extracting juice about 400ml, point morning, twice empty stomach temperature in evening
Clothes.It within five days, it is a course for the treatment of.Avoid cold and uncooked food during treatment the thing of pungent stimulation.
Four, criterion of therapeutical effect:
(1) cure: patient's pain, swollen, picotement disappearance, joint motion is normal；
(2) effective: patient's pain, swollen, picotement substantially alleviate；
(3) effective: patient's pain, swollen, picotement have alleviated；
(4) invalid: sings and symptoms is all not improved, symptom is the most front.
Five, therapeutic effect: in this clinical observation case, take medicine 5-10 the course for the treatment of, 64 examples of fully recovering, follow up a case by regular visits to have no recurrence；Aobvious
Imitate 12 examples, effective 6 examples, invalid 3 examples.During treatment, centering clinical drug causes all types of anaphylaxis, causes suspected of medicine
In terms of each system of human body, organ, the function of tissue and form abnormal, cause mutagenesis reaction, the medicines such as cancer suspected of medicine
Dependency and think that other untoward reaction important or valuable are evaluated, i.e. in adverse drug reaction (ADR) comment
, there is not untoward reaction and toxic and side effects in valency.
Six, model case:
Case 1:
Poplar, female, 65 years old.Private prosecution time medical: right knee joint is swollen pain, numbness, time movable, pain increases the weight of, and during inertia, pain subtracts
Gently, difficulty in walking, activities adverse.X line shows as joint space and narrows, joint margins lip sample hypertrophy.It is diagnosed as: right knee joint
Hyperosteogeny.Taking 3 courses for the treatment of of medicament prepared by Chinese medicine composition of the present invention, swollen pain, numbness alleviate, and can walk；Continue clothes
With 3 courses for the treatment of, swollen pain, numb disappearance, joint motion normally, is cured.Follow up a case by regular visits to after half a year without recurrence.
Case 2:
Huang, man, 51 years old.Readme: have a dull ache in knee, tenderness, soreness of the waist and knees, difficulty in walking, pitching is changed one's position unfavorable, overcast and rainy
It increases the weight of.With dizziness, tinnitus, dizzy.X line shows as articular cartilage and substantially destroys, and joint space substantially narrows.It is diagnosed as:
Knee joint hyperosteogeny.5 courses for the treatment of of medicament prepared with Chinese medicine composition of the present invention, pain substantially alleviates, the disease such as dizziness, tinnitus
Shape disappears；Continue to take 3 courses for the treatment of, all transference cures, recovery from illness.
Claims (2)
1. the Chinese medicine composition treating hyperosteogeny, it is characterised in that: its raw material of Chinese medicine and weight be: Radix Flemingiae Philippinensis
10-30 part, Bi 5-25 part, Semen Coicis 5-25 part, Rhizoma Atractylodis 5-20 part, Radix Et Caulis Acanthopanacis Senticosi 5-25 part, deer grass 5-25 part, Radix Fici tikouae 5-
25 parts, Rhizoma Curcumae Longae 5-20 part, Radix Stellariae Yunnanensis 5-25 part, Rhizoma Curculiginis 5-25 part, Radix Celastri Orbiculati 5-25 part, Radix Zanthoxyli 5-20 part, ferrum bag
Gold 5-25 part, Carapax et Plastrum Testudinis 5-25 part, Flos Woodfordiae Fruticosae 5-25 part, Cortex Cinnamomi 5-20 part, Herba Lysimachiae Clethroids (Radix Seu Herba Lysimachiae Clethroidis) 5-25 part, Radix Rubiae 5-25 part, thorn youth fruit 5-
25 parts, Radix Oenotherae erythrosepalae 5-25 part, Rhizoma Arisaematis 5-20 part, Caulis et Folium (Gouaniae Leptostachyae) 5-25 part, Radix Cyanotis vagae 5-25 part, Radix Glycyrrhizae 5-15 part.
A kind of Chinese medicine composition treating hyperosteogeny, it is characterised in that: its raw material of Chinese medicine and weight
Amount part proportioning is: Radix Flemingiae Philippinensis 20 parts, Bi 15 parts, Semen Coicis 15 parts, Rhizoma Atractylodis 10 parts, Radix Et Caulis Acanthopanacis Senticosi 15 parts, deer grass 15 parts, Radix Pachyrhizi Erosi
Root 15 parts, 10 parts of Rhizoma Curcumae Longae, Radix Stellariae Yunnanensis 15 parts, Rhizoma Curculiginis 15 parts, Radix Celastri Orbiculati 15 parts, Radix Zanthoxyli 10 parts, Radix berchemiae lineatae 15 parts, Testudinis
Plate 15 parts, Flos Woodfordiae Fruticosae 15 parts, Cortex Cinnamomi 10 parts, Herba Lysimachiae Clethroids (Radix Seu Herba Lysimachiae Clethroidis) 15 parts, 15 parts of Radix Rubiae, thorn youth fruit 15 parts, Radix Oenotherae erythrosepalae 15 parts, Rhizoma Arisaematis
10 parts, Caulis et Folium (Gouaniae Leptostachyae) 15 parts, Radix Cyanotis vagae 15 parts, 10 parts of Radix Glycyrrhizae.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610701268.7A CN106177775A (en) | 2016-08-23 | 2016-08-23 | A kind of Chinese medicine composition treating hyperosteogeny |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610701268.7A CN106177775A (en) | 2016-08-23 | 2016-08-23 | A kind of Chinese medicine composition treating hyperosteogeny |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN106177775A true CN106177775A (en) | 2016-12-07 |
Family
ID=57524025
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610701268.7A Pending CN106177775A (en) | 2016-08-23 | 2016-08-23 | A kind of Chinese medicine composition treating hyperosteogeny |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN106177775A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107029083A (en) * | 2017-05-02 | 2017-08-11 | 广州智润生物制药科技有限公司 | A kind of pharmaceutical composition for treating osteoproliferation |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101390988A (en) * | 2008-10-23 | 2009-03-25 | 侯召亮 | Medicine for treating hyperosteogeny |
| CN102920887A (en) * | 2012-11-29 | 2013-02-13 | 广西梧州三鹤药业有限公司 | Chinese medicinal composition for treating hyperostosis |
| CN105079513A (en) * | 2015-09-25 | 2015-11-25 | 刘连强 | Traditional Chinese medicine composition for treating osteoproliferation |
-
2016
- 2016-08-23 CN CN201610701268.7A patent/CN106177775A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101390988A (en) * | 2008-10-23 | 2009-03-25 | 侯召亮 | Medicine for treating hyperosteogeny |
| CN102920887A (en) * | 2012-11-29 | 2013-02-13 | 广西梧州三鹤药业有限公司 | Chinese medicinal composition for treating hyperostosis |
| CN105079513A (en) * | 2015-09-25 | 2015-11-25 | 刘连强 | Traditional Chinese medicine composition for treating osteoproliferation |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107029083A (en) * | 2017-05-02 | 2017-08-11 | 广州智润生物制药科技有限公司 | A kind of pharmaceutical composition for treating osteoproliferation |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102512630B (en) | Traditional Chinese medicine composition for treating gallbladder calculus | |
| CN103784769A (en) | Chinese herbal preparation for treating orthopedic diseases | |
| CN105288230A (en) | Traditional Chinese medicine composition for treating paralysis | |
| CN103211932B (en) | Traditional Chinese medicine composition for treating rheumatism | |
| CN105560662A (en) | External-use traditional Chinese medicine composition for treating knee osteoarthritis | |
| CN103536777A (en) | Traditional Chinese medicinal composition for treating knee osteoarthritis | |
| CN104587368A (en) | Traditional Chinese medicine composition for treating spleen-yang and kidney-yang deficiency | |
| CN101700389B (en) | Traditional Chinese medicine composite for curing rheumatism and rheumatoid diseases | |
| CN103041301B (en) | Traditional Chinese medicine composition for treating icterohepatitis | |
| CN103316296B (en) | Traditional Chinese medicine composition for treating hyperostosis | |
| CN107115493A (en) | It is a kind of to treat Chinese medicine composition of fracture and its production and use | |
| CN105343442A (en) | External medicament for treating lubar intervertebral disc protrusion and preparation method thereof | |
| CN102512560B (en) | Traditional Chinese medicinal composition for treating arthromyodynia | |
| CN104758720A (en) | Traditional Chinese medicine composition for treating impotence | |
| CN106177775A (en) | A kind of Chinese medicine composition treating hyperosteogeny | |
| CN102512543B (en) | Chinese medicinal composition for treating rheumatoid arthritis | |
| CN105169279A (en) | Traditional Chinese medicine composition for treating knee joint bone hyperplasia | |
| CN104857463A (en) | Traditional Chinese medicine combination for curing metrorrhagia and metrostaxis | |
| CN104758527A (en) | Traditional Chinese medicine composition for treating pain in waists and legs | |
| CN103585483A (en) | Traditional Chinese medicine composition for treating knee osteoarthritis and preparation method of same | |
| CN103191305A (en) | Traditional Chinese medicine composition for treating hyperosteogeny | |
| CN103285108B (en) | Chinese medicinal composition treating lumbago | |
| CN103127349B (en) | Medicine for treating traumatic injury | |
| CN103356951B (en) | A kind of Chinese medicine composition for the treatment of cardiac blood supply deficiency | |
| CN106924673A (en) | A kind of Chinese medicine composition for treating osteoproliferation and its medicament preparation method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20161207 |